Lorne Kenneth Abony is Director of PLURISTEM THERAPEUTICS INC. Currently has a direct ownership of 36,750 shares of PSTI, which is worth approximately $25,725. The most recent transaction as insider was on Jan 23, 2024, when has been sold 36,750 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 36.8K
0% 3M change
n/a 12M change
Total Value Held $25,725

Lorne Kenneth Abony Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 23 2024
BUY
Grant, award, or other acquisition
-
36,750 Added 50.0%
36,750 Common Stock
LKA

Lorne Kenneth Abony

Director
Haifa, L3

Track Institutional and Insider Activities on PSTI

Follow PLURISTEM THERAPEUTICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PSTI shares.

Notify only if

Insider Trading

Get notified when an Pluristem Therapeutics Inc insider buys or sells PSTI shares.

Notify only if

News

Receive news related to PLURISTEM THERAPEUTICS INC

Track Activities on PSTI